Comparative effect of lansoprazole/amoxicillin and omeprazole/amoxicillin for eradication of Helicobacter pylori in duodenal ulcer patients;Wirkungsvergleich von Lansoprazol/Amoxicillin mit Omeprazol/Amoxicillin zur Eradikation von Helicobacter pylori bei Patienten mit Duodenalulkus

Schweizerische Medizinische Wochenschrift

Volumn 127, Issue 17, 1997, Pages 722-727

  Kayser, S ^a,e   Flury, R ^b   Zbinden, R ^c   Fried, M ^a   Wirth, H P ^a,d  

^a Abteilung Gastroenterologie   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Stadtspital Triemli Departement fur Innere Medizin Abteilung fur Gastroenterologie   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; LANSOPRAZOLE; OMEPRAZOLE;

ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DUODENUM ULCER; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; RANDOMIZED CONTROLLED TRIAL;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; AGED, 80 AND OVER; AMOXICILLIN; ANTI-ULCER AGENTS; DRUG THERAPY, COMBINATION; DUODENAL ULCER; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PENICILLINS; PROSPECTIVE STUDIES; SMOKING; TREATMENT OUTCOME;

EID: 0030947669     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Marshall BJ: Campylobacter pylori: its link to gastritis and peptic ulcer disease. Rev Infect Dis 1990; 12: S87-S93.
2. Tygat GNJ, Lee A, Graham DY, Dixon MF, Rokkas T: The role of infectious agents in peptic ulcer disease. Gastroenterol Int 1993; 6: 76-89.
3. Warren JR, Marschall B: Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983/I: 1273-1275.
4. Blaser MJ: Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 1990; 161: 626-633.
5. Wirth HP: Gastroduodenale Ulkuskrankheit: Neues zur Pathogenese. Praxis 1995; 84: 579-580.
6. NIH Consensus Conference: Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65-69.
7. Marshall BJ: Helicobacter pylori. Am J Gastroenterol 1994; 89 (Suppl.): 116-128.
8. Tytgat GNJ: Helicobacter pylori: recent developments. Eur J Gastroenterol Hepatol 1995; 4: 289-321.
9. Wadström T: An update on Helicobacter pylori. Cur Opinion Gastroenterol 1995; 11: 69-75.
10. Walsh JH, Peterson LW: The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N Engl J Med 1995; 15: 984-991.
11. Labenz J, Rühl GH, Bertrams J, Börsch G: Medium- or high-dose omeprazole plus amoxicillin eradicates Helicobacter pylori in gastric ulcer disease. Am J Gastroenterol 1994; 5: 726-730.
12. Collins R, Beattie S, O'Morain C: High dose omeprazole plus amoxicillin in the treatment of acute duodenal ulcer. Ir J Med Sci 1992; 161 (Suppl. 10): 96-97.
13. Logan R, Rubio MA, Gummet PA, Hegarty B, Walker MM et al.: Omeprazole and amoxicillin suspension for Helicobacter pylori. Ir J Med Sci 1992; 161: (Suppl. 10): 16.
14. Bayerdörffer E, Mannes GA, Sommer A, Höchter W, Weingart J et al.: High dose omeprazole treatment with amoxicillin eradicates Helicobacter pylori. Eur J Gastroenterol Hepatol 1992; 4: 697-702.
15. Labenz J, Geynes E. Rühl GH, Börsch G: Omeprazole plus amoxicillin: efficacy of various regimes to eradicate Helicobacter pylori. Am J Gastroenterol 1993; 88: 491-495.
16. Iwahi T, Satoh H, Nakao M, Iwasaki T, Yamazaki T et al.: Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrob Agents Chemother 1991; 3: 490-496.
17. Megraud F, Boyanova L, Lamouliatte H: Activity of lansoprazole against Helicobacter pylori [Letter]. Lancet 1991; 337: 1486.
18. Unge P, Gnad A, Gnarpe H, Olsson J: Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? Scand J Gastroenterol 1989; 24 (Suppl. 167): 49-54.
19. De Koster E, Nyst JF, Deprez C, Jonas C, Denis P et al.: HP treatment: disappointing results with amoxicillin plus omeprazole. Gastroenterology 1992; 102: A58.
20. Zala G, Giezendanner S, Flury R, Wüst J, Wirth HP: Omeprazol/Amoxicillin: beeinträchtigte Eradikation von Helicobacter pylori durch Rauchen, aber nicht durch eine Omeprazol-Vorbehandlung. Schweiz Med Wochenschr 1994; 124: 1398-1404.
21. Nakao M: Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori. J Clin Gastroenterol 1995; 20 (Suppl. 1): S32-S37.
22. Barradell LB, Faulds D, McTavish D: Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders. Drugs 1992; 44: 225-250.
23. Hatlebakk JG, Berstad A, Carling L, Svedberg LE, Unge P et al.: Lansoprazole vs. omeprazole in short-term treatment of reflux esophagitis - results of Scandinavian multicenter trial. Am Gastroenterol Ass 1992: A10-13.
24. Londong A, Barth H, Dammann HG, Hengels KJ, Kleinert L et al.: Dose related healing of duodenal ulcer with the proton pump inhibitor lansoprazole. Aliment Pharmacol Ther 1991; 5: 245-254.
25. Metz DC, Pisegna JR, Ringham GR, Fishbeyn VA, Benya RV et al.: Efficacy and safety of lansoprazole in patients with Zollinger-Ellison-syndrome (ZES). Am Gastroenterol Ass 1992: A346.
26. Labenz J, Stolte M, Domian C: Omeprazole plus amoxicillin or clarithromycin for eradication of H. pylori in DU disease. Am J Gastroenterol 1993; 88: 1511.
27. Zala G, Wirth HP, Bauer S, Wüst J, Flury R et al.: Eradikation Metronidazol-resistenter Helicobacter pylori: Ist Omeprazol/Amoxicillin eine therapeutische Alternative? Schweiz Med Wochenschr 1994; 124: 1385-1390.
28. De Korwin JD, Joubert M, Bazin N: Lansoprazole versus lansoprazole plus antibiotics in the treatment of Helicobacter pylori gastric infection. Gastroenterology 1993; 104 (Suppl.): A67.
29. Lamouliatte H: Adjuvant therapy for Helicobacter pylori eradication: role of lansoprazole in clinical studies. J Clin Gastroenterol 1995; 20 (Suppl. 1): S28-S31.
30. Labenz J, Leverkus F, Börsch G: Omeprazole plus amoxicillin for cure of Helicobacter pylori infection. Factors influencing the treatment success. Scand J Gastroenterol 1994; 29: 1070-1075.
31. Labenz J, Stolte M, Blum AL, Jorias I, Leverkus F et al.: Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin. Gut 1995; 37: 39-43.
32. Louw JA, van Rensburg C, Simjee AE: Lansoprazole versus omeprazole in duodenal ulcer healing. S Afr Med J 1993; 83: A777.
33. Petite JP, Slama JL, Licht H: Lansoprazole and omeprazole in the treatment of duodenal ulcer. A multicenter double blind comparative trial. Gastroenterol Clin Biol 1993; 17: 334-340.
34. Ekström P, Unge P, Ahlberg J: Lansoprazole versus omeprazole in active duodenal ulcer - a healing study. Scand J Gastroenterol 1992; 27 (Suppl. 190, A34): 40.
35. Bayerdörffer E, Miehlke S, Mannes GA, Sommer A, Höchter W et al.: Double blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers. Gastroenterology 1995; 108: 1412-1417.
36. Mannes GA, Bayerdörffer E, Hele C: An increasing dose of omeprazole combined with amoxicillin increases the eradication rate of Helicobacter pylori. Gastroenterology 1993; 104: A140.
37. Zala G, Schwery ST, Giezendanner S, Flury R, Wirth HP: Wirksamkeit der Tripeltherapie zur Eradikation von H. pylori bei Therapieversagern mit Omeprazol/Amoxicillin. Schweiz Med Wochenschr 1996; 126: 153-158.